Market Overview The Non-Invasive Cancer Diagnostics Market includes a broad range of technologies such as liquid biopsies, circulating tumor DNA (ctDNA) analysis, circulating tumor cells (CTCs) detection, advanced imaging modalities, and biomarker-based assays. These tools allow clinicians to identify cancer at earlier stages, monitor treatment response, and detect recurrence with minimal...